Annals of the Rheumatic Diseases: 79 (Suppl 1)
June 2020 – Volume 79 – Suppl 1 …
June 2020 – Volume 79 – Suppl 1 …
Objectives Inflammatory cytokines that signal through the Janus kinases–signal transducer and activator of transcription (JAK-STAT) pathway, especially interferons (IFNs), are implicated in Sjögren’s disease (SjD).…
Globally, there has been a growing interest in addressing gender disparities in leadership positions within rheumatology,1 editorial boards of rheumatology journals,2 conference speakers3 and authorship…
A 51-year-old man presented with persistent pain localised to the right clavicle after consuming 1600 mL of beer. The patient has a medical history of gout…
Objectives To investigate the mechanism by which intestinal epithelial cell (IEC) death induces arthritis. Methods IEC death was assessed by staining for necroptosis and apoptosis…
Objectives To obtain an overview of recent evidence on efficacy and safety of pharmacological treatments in psoriatic arthritis (PsA). Methods This systematic literature research (SLR)…
Objective New modes of action and more data on the efficacy and safety of existing drugs in psoriatic arthritis (PsA) required an update of the…
Objective To investigate the ability of MRI-based synthetic CT (sCT), low-dose CT (ldCT) and radiography to detect spinal new bone formation (NBF) in patients with…
Objective This post hoc analysis of the FINCH 1–3 ([NCT02889796][1], [NCT02873936][2] and [NCT02886728][3]) studies assessed specific effects of filgotinib on pain control and their relationship…
Objectives Biosimilar-originator equivalence has been demonstrated in phase 3 trials in a few indications of infliximab, etanercept and adalimumab. The objective of our study was…
Objective To compare the 1-year retention rate of secukinumab in axial spondyloarthritis (axSpA) and its predisposing factors with regard to its time of initiation (eg,…